Evidence map›Paper›PMID 27601573›Full record

ArticlemBio2016

Fluorescence-Based Flow Sorting in Parallel with Transposon Insertion Site Sequencing Identifies Multidrug Efflux Systems in Acinetobacter baumannii.

Karl A Hassan, Amy K Cain, TaoTao Huang, Qi Liu, Liam D H Elbourne, Christine J Boinett, Anthony J Brzoska, Liping Li, Martin Ostrowski, Nguyen Thi Khanh Nhu and 4 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Update on Multidrug Resistance Efflux Pumps in Acinetobacter spp.Antimicrobial agents and chemotherapy · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Recent Advances in Genetic Tools forFrontiers in genetics · 2020
    Review
  15. Review
  16. New microbes and new infections · 2019
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 4 countries.

Karl A HassanDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia karl.hassan@mq.edu.au.
Amy K CainWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom Liverpool School of Tropical Medicine, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
TaoTao HuangDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.
Qi LiuDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.
Liam D H ElbourneDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.
Christine J BoinettWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Anthony J BrzoskaDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.
Liping LiDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.
Martin OstrowskiDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.
Nguyen Thi Khanh NhuThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
Tran Do Hoang NhuThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Stephen BakerThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, Oxford University, Oxford, United Kingdom.
Julian ParkhillWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.ORCID 0000-0002-7069-5958
Ian T PaulsenDepartment of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.
Macquarie University · AUWellcome Sanger Institute · GBNuffield Orthopaedic Centre · GBOxford University Clinical Research Unit · VNThe University of Queensland · AUUniversity of Liverpool · GB

Funding

Medical Research Council G1100100Wellcome Trust 098051Wellcome Trust 100087/Z/12/Z
6 · The paper itself

Abstract

unlabelledMultidrug efflux pumps provide clinically significant levels of drug resistance in a number of Gram-negative hospital-acquired pathogens. These pathogens frequently carry dozens of genes encoding putative multidrug efflux pumps. However, it can be difficult to determine how many of these pumps actually mediate antimicrobial efflux, and it can be even more challenging to identify the regulatory proteins that control expression of these pumps. In this study, we developed an innovative high-throughput screening method, combining transposon insertion sequencing and cell sorting methods (TraDISort), to identify the genes encoding major multidrug efflux pumps, regulators, and other factors that may affect the permeation of antimicrobials, using the nosocomial pathogen Acinetobacter baumannii A dense library of more than 100,000 unique transposon insertion mutants was treated with ethidium bromide, a common substrate of multidrug efflux pumps that is differentially fluorescent inside and outside the bacterial cytoplasm. Populations of cells displaying aberrant accumulations of ethidium were physically enriched using fluorescence-activated cell sorting, and the genomic locations of transposon insertions within these strains were determined using transposon-directed insertion sequencing. The relative abundance of mutants in the input pool compared to the selected mutant pools indicated that the AdeABC, AdeIJK, and AmvA efflux pumps are the major ethidium efflux systems in A. baumannii Furthermore, the method identified a new transcriptional regulator that controls expression of amvA In addition to the identification of efflux pumps and their regulators, TraDISort identified genes that are likely to control cell division, cell morphology, or aggregation in A. baumannii IMPORTANCE: Transposon-directed insertion sequencing (TraDIS) and related technologies have emerged as powerful methods to identify genes required for bacterial survival or competitive fitness under various selective conditions. We applied fluorescence-activated cell sorting (FACS) to physically enrich for phenotypes of interest within a mutant population prior to TraDIS. To our knowledge, this is the first time that a physical selection method has been applied in parallel with TraDIS rather than a fitness-induced selection. The results demonstrate the feasibility of this combined approach to generate significant results and highlight the major multidrug efflux pumps encoded in an important pathogen. This FACS-based approach, TraDISort, could have a range of future applications, including the characterization of efflux pump inhibitors, the identification of regulatory factors controlling gene or protein expression using fluorescent reporters, and the identification of genes involved in cell replication, morphology, and aggregation.

Indexed as

Drug Resistance, Multiple, BacterialAcinetobacter baumanniiAnti-Infective AgentsBiological Transport, ActiveDNA Transposable ElementsEthidiumFlow CytometryFluorescent DyesGene LibraryHigh-Throughput Screening AssaysMembrane Transport ProteinsMutagenesis, InsertionalSequence Analysis, DNAStaining and LabelingAnti-Infective AgentsDNA Transposable ElementsEthidiumFluorescent DyesMembrane Transport Proteins

Identifiers

PMID27601573
PMCPMC5013296
OpenAlexW2517945749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.